Leerink Swann Makes Comments on Human Genome Sciences (HGSI); Sees Value in Prime Candidates
Tweet Send to a Friend
Leerink Swann comments on Human Genome Sciences (Nasdaq: HGSI). Price target $30.
Leerink analyst says, "In 12 months, both of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink analyst says, "In 12 months, both of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
